The longer production is halted, the harder it is to restart the process and keep the supply chain fluid.

One of the goals of the Trump administration is to reclaim all of the supply chain and manufacturing capability that would otherwise exist if the playing field were level.

The global food supply chain is a multitrillion-dollar industry. That's the market we're thinking about disrupting.

The 'adaptive supply chain' has been the buzz over the last few years.

CDC is made up of Pivotal, IMI, which is a supply chain player, and Ross, which is an ERP player. CDC has integrated none of these into a suite. This new entity was going to be made up of all these new pieces, plus Onyx. Our shareholders were going to walk away being a small, minority owner in CDC, as opposed to being 100 percent owners in Onyx, a company that is doing very well right now.

But there are plenty of stops along the supply chain with weaknesses: the start of hurricane season, Iraqi production hanging on by a thread, recent problems in Ecuador, no sign of growth in Russian production and continued speculative interest in being 'long' in this market. The increases of the last month reflect that backdrop.